These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7733160)

  • 21. Hemodialysis catheter design and catheter performance: a randomized controlled trial.
    Van Der Meersch H; De Bacquer D; Vandecasteele SJ; Van den Bergh B; Vermeiren P; De Letter J; De Vriese AS
    Am J Kidney Dis; 2014 Dec; 64(6):902-8. PubMed ID: 24713222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of neonatal aortic thrombosis with urokinase.
    Hustead VA; Wicklund BM
    Am J Pediatr Hematol Oncol; 1990; 12(3):336-9. PubMed ID: 2240482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with urokinase for thrombotic complications of the bio-carbon prosthesis for hemodialysis.
    Novoa D; Martínez M; Romero R; Arcocha V; del Río A
    Clin Nephrol; 1985 Dec; 24(6):315. PubMed ID: 4075601
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombotic disease in newborn infants.
    Schmidt B; Zipursky A
    Clin Perinatol; 1984 Jun; 11(2):461-88. PubMed ID: 6378488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis.
    Nguyen TV; Dikun M
    Am J Health Syst Pharm; 2004 Sep; 61(18):1922-4. PubMed ID: 15487882
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombolytic therapy: Current status.
    Fratantoni JC; Ness P; Simon TL
    N Engl J Med; 1975 Nov; 293(21):1073-8. PubMed ID: 1178024
    [No Abstract]   [Full Text] [Related]  

  • 27. Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C.
    Wiernikowski JT; Crowther M; Clase CM; Ingram A; Andrew M; Chan AK
    Lancet; 2000 Jun; 355(9222):2221-2. PubMed ID: 10881901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of urokinase in the occlusion of arteriovenous fistulae for chronic hemodialysis].
    Iberti M; Musante F; Spinoglio G; Della Volpe M; Iacovoni P; Ortensia A; Piacentino A; Veronesi GV
    Minerva Nefrol; 1983; 30(4):207-11. PubMed ID: 6664607
    [No Abstract]   [Full Text] [Related]  

  • 29. Managing catheter dysfunction for better patient outcomes: a team approach.
    Dinwiddie LC
    Nephrol Nurs J; 2004; 31(6):653-60, 671; quiz 661-2. PubMed ID: 15686329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase efficacy in the restoration of hemodialysis catheter function.
    Meers C; Toffelmire EB
    J CANNT; 1998; 8(2):17-9. PubMed ID: 9807329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic treatment of catheter-related thrombus in pediatrics.
    Ruble K; Long C; Connor K
    Pediatr Nurs; 1994; 20(6):553-7. PubMed ID: 7708454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteplase versus urokinase for occluded hemodialysis catheters.
    Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
    Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.
    Castner D
    Nephrol Nurs J; 2001 Aug; 28(4):403-4, 407-10. PubMed ID: 12143462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Are permanent catheters a safe vascular access in chronically hemodialysed children?].
    Zachwieja K; Miklaszewska M; Drozdz D; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():166-72. PubMed ID: 16898521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.
    Ouriel K; Veith FJ; Sasahara AA
    N Engl J Med; 1998 Apr; 338(16):1105-11. PubMed ID: 9545358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reestablishing patency in the occluded implanted central venous access device (VAD)--Part 2.
    Simonson G; Brown LH; Wantroba I
    Crit Care Nurse; 1989 Oct; 9(9):13-20. PubMed ID: 2805765
    [No Abstract]   [Full Text] [Related]  

  • 37. [Permanent catheter as an alternative vascular access for hemodialysis].
    Miłkowski A; Kirker A; Smoleński O; Hartwich A; Pietkun Z
    Przegl Lek; 1996; 53(11):805-10. PubMed ID: 9173444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical application of an algorithm for the thrombolytic treatment of occluded vascular access devices.
    Bagnall-Reeb H; Ruccione K
    J Pediatr Oncol Nurs; 1993 Apr; 10(2):79-82. PubMed ID: 8489744
    [No Abstract]   [Full Text] [Related]  

  • 39. Using urokinase to restore patency in double lumen catheters.
    Northsea C
    ANNA J; 1994 Aug; 21(5):261-4, 273. PubMed ID: 8080337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical application of the urokinase-immobilized polyurethane catheter].
    Matsumoto M; Okamoto Y; Konishi Y; Nomoto S; Soneda J; Fujiwara Y; Nishimura K; Ban T; Suyama K
    Nihon Geka Hokan; 1986 Sep; 55(5):727-31. PubMed ID: 3579460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.